Abstract
The aim of this study was to investigate the effect of functionalized titanium (Ti) with alendronate (Aln) and bone morphogenic protein-2 (BMP-2) for enhancement of osteoblast activity in vitro. Aln and/or BMP-2 were sequentially immobilized to the heparinized-Ti (Hep-Ti) surface. The compositions of pristine Ti and Hep-Ti with or without Aln and/or BMP-2 were characterized by scanning electron microscope (SEM) and X-ray photoelectron spectroscopy (XPS). Aln and/or BMP-2 onto Hep-Ti surface were released in a sustained manner. Osteoblast activities on all Ti substrates were investigated by cell proliferation assays, alkaline phosphate (ALP) activity, calcium deposition, gene expressions of osteocalcin and osteopontin. Aln/BMP-2/Hep-Ti significantly enhanced ALP activity, calcium mineral deposition, and gene expressions of osteoblast cells when compared with pristine Ti, Aln/Hep-Ti, and BMP-2/Hep-Ti. From these results, functionalized Ti substrates with alendronate and BMP-2 such as Aln/BMP-2/Hep-Ti are a promising material for the enhanced osteoblast activities in orthopedic and dental fields.
Similar content being viewed by others
Abbreviations
- Ti:
-
Titanium
- Aln:
-
Alendronate
- BMP-2:
-
Bone morphogenic protein-2
- Hep-Ti:
-
Heparinized-Ti
- XPS:
-
X-ray photoelectron spectroscopy
- ALP:
-
Alkaline phosphate
- Aln/Hep-Ti:
-
Alendronate-immobilized Hep-Ti
- BMP-2/Hep-Ti:
-
BMP-2-immobilized Hep-Ti
- Aln/BMP-2/Hep-Ti:
-
Alendronate and BMP-2-immobilized Hep-Ti
- Hep-DOPA:
-
Heparin-dopamine
References
L Le Guéhennec, A Soueidan, P Layrolle, et al., Surface treatments of titanium dental implants for rapid osseointegration, Dent Mater, 23, 844 (2007).
Z Schwartz, BD Boyan, Underlying mechanisms at the bonebiomaterial interface, J Cell Biochem, 56, 340 (1994).
G Balasundaram, TJ Webster, Increased osteoblast adhesion on nanograined Ti modified with KRSR, J Biomed Mater Res A, 80, 602 (2007).
C Chen, IS Lee, SM Zhang, et al., Biomimetic apatite formation on calcium phosphate-coated titanium in Dulbecco’s phosphate-buffered saline solution containing CaCl2 with and without fibronectin, Acta Biomater, 6, 2274 (2010).
Y Ku, CP Chung, JH Jang, The effect of the surface modification of titanium using a recombinant fragment of fibronectin and vitronectin on cell behavior, Biomaterials, 26, 5153 (2005).
K Oya, Y Tanaka, H Saito, et al., Calcification by MC3T3-E1 cells on RGD peptide immobilized on titanium through electrodeposited PEG, Biomaterials, 30, 1281 (2009).
Z Shi, KG Neoh, ET Kang, et al., Bacterial adhesion and osteoblast function on titanium with surface-grafted chitosan and immobilized RGD peptide, J Biomed Mater Res A, 86, 865 (2008).
L Zhang, UD Hemraz, H Fenniri, et al., Tuning cell adhesion on titanium with osteogenic rosette nanotubes, J Biomed Mater Res A, 95, 550 (2010).
R Leesungbok, SW Lee, SJ Ahn, et al., Specific temporal culturing and microgroove depth influence osteoblast differentiation of human periodontal ligament cells grown on titanium substrats, Tissue Eng Regen Med, 9, 128 (2012).
OA Arosarena, D Puleo, In vitro effects of combined and sequential bone morphogenetic protein administration, Arch Facial Plast Surg, 9, 242(2007).
SD Cook, MW Wolfe, SL Salkeld, et al., Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates, J Bone Joint Surg Am, 77, 734 (1995).
SE Kim, O Jeon, JB Lee, et al., Enhancement of ectopic bone formation by bone morphogenetic protein-2 delivery using heparin-conjugated PLGA nanoparticles with transplantation of bone marrow-derived mesenchymal stem cells, J Biomed Sci, 15, 771 (2008).
EA Wang, V Rosen, JS D’Alessandro, et al., Recombinant human bone morphogenetic protein induces bone formation, Proc Natl Acad Sci U S A, 87, 2220 (1990).
SE Kim, SH Song, YP Yun, et al., The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function, Biomaterials, 32, 366 (2011).
YJ Lee, Y Kim, JY Kim, et al., Effect of different concentrations of Escherichia coli-derived rhBMP-2 coating on osseointegration of Implants in dogs, Tissue Eng Regen Med, 9, 209 (2012).
DL Diefenderfer, AM Osyczka, JP Garino, et al., Regulation of BMP-induced transcription in cultured human bone marrow stromal cells, J Bone Joint Surg Am, 85A, 19 (2003).
F Lecanda, LV Avioli, SL Cheng, et al., Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2, J Cell Biochem, 67, 386 (1997).
S Itoh, M Matubara, T Kawauchi, et al., Enhancement of bone ingrowth in a titanium fiber mesh implant by rhBMP-2 and hyaluronic acid, J Mater Sci Mater Med, 12, 575 (2001).
Z Shi, KG Neoh, ET Kang, et al., Titanium with surface-grafted dextran and immobilized bone morphogenetic protein-2 for inhibition of bacterial adhesion and enhancement of osteoblast functions, Tissue Eng Part A, 15, 417 (2009).
Z Shi, KG Neoh, ET Kang, et al., Surface functionalization of titanium with carboxymethyl chitosan and immobilized bone morphogenetic protein-2 for enhanced osseointegration, Biomacromolecules, 10, 1603 (2009).
B Wen, M Karl, D Pendrys, et al., An evaluation of BMP-2 delivery from scaffolds with miniaturized dental implants in a novel rat mandible model, J Biomed Mater Res B Appl Biomater, 97, 315 (2011).
DW Lee, YP Yun, K Park, et al., Gentamicin and bone morphogenic protein-2 (BMP-2)-delivering heparinizedtitanium implant with enhanced antibacterial activity and osteointegration, Bone, 50, 974 (2012).
R Sasisekharan, S Ernst, G Venkataraman, et al., On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans, Angiogenesis, 1, 45 (1997).
AR Holmberg, UH Lerner, AA Alayia, et al., Development of a novel poly bisphosphonate conjugate for treatment of skeletal metastasis and osteoporosis, Int J Oncol, 37, 563 (2010).
I Lambrinoudaki, G Christodoulakos, D botsis, et al., Bisphosphonates, Ann N Y Acad Sci, 1092, 397 (2006).
NJ Malden, AY Pai, Oral bisphosphonate associated osteonecrosis of the jaws: three case reports, Br Dent J, 203, 93 (2007).
S Oura, H Tanino, T Yoshimasu, et al., Bisphosphonate therapy for bone metastases from breast cancer: clinical results and a new therapeutic approach, Breast Cancer, 7, 307 (2000).
RG Russell, Bisphosphonates: from bench to bedside, Ann N Y AcadSci, 1068, 367 (2006).
RG Russell, Z Xia, JE Dunford, et al., Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy, Ann N Y Acad Sci, 1117, 209 (2007).
SL Silverman, Paget disease of bone: therapeutic options, J Clin Rheumatol, 14, 299 (2008).
Y Inoue, I Hisa, S Seino, et al., Alendronate induces mineralization in mouse osteoblastic MC3T3-E1 cells: regulation of mineralization-related genes, Exp Clin Endocrinol Diabetes, 118, 719 (2010).
HK Kim, JH Kim, AA Abbas, et al., Alendronate enhances osteogenic differentiation of bone marrow stromal cells: a preliminary study, Clin Orthop Relat Res, 467, 3121 (2009).
S Panzavolta, P Torricelli, B Bracci, et al., Functionalization of biomimetic calcium phosphate bone cements with alendronate, J Inorg Biochem, 104, 1099 (2010).
F von Knoch, C Jaquiery, M Kowalsky, et al., Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells, Biomaterials, 26, 6941 (2005).
CZ Wang, SM Chen, CH Chen, et al., The effect of the local delivery of alendronate on human adipose-derived stem cellbased bone regeneration, Biomaterials, 31, 8674 (2010).
HJ Moon, YP Yun, CW Han, et al., Effect of heparin and alendronate coating on titanium surfaces on inhibition of osteoclast and enhancement of osteoblast function, Bio chem Biophys Res Commun, 413, 194 (2011).
SE Kim, DH Suh, YP Yun, et al., Local delivery of alendronate eluting chitosan scaffold can effectively increase osteoblast functions and inhibit osteoclast differentiation, J Mater Sci Mater Med, 23, 2739 (2012).
PH Chua, KG Neoh, ET Kang, et al., Wang Surface functionalization of titanium with hyaluronic acid/chitosan polyelectrolyte multilayers and RGD for promoting osteoblast functions and inhibiting bacterial adhesion, Biomaterials, 29, 1412 (2008).
T Ishibe, T Goto, T Kodama, et al., Bone formation on apatitecoated titanium with incorporated BMP-2/heparin in vivo, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 108, 867 (2009).
JS Park, K Park, DG Woo, et al., Triple constructs consisting of nanoparticles and microspheres for bone-marrow-derived stromal-cell-delivery microscaffolds, Small, 4, 1950 (2008).
I Pountos, T Georgouli, K Henshaw, et al., The effect of bone morphogenic protein-2, bone morphogenic protein-7, parathyroid hormone, and platelet-derived growth factor on the proliferation and osteogenic differentiation of mesenchymal stem cells derived from osteoporotic bone, J Orthop Trauma, 24, 552 (2010)
PL Kuo, YT Huang, CH Chang, et al., Bone morphogenic protein-2 and -4 (BMP-2 and -4) mediates fraxetin-induced maturation and differentiation in human osteoblast-like cell lines, Biol Pharm Bull, 29, 119 (2006).
K Turksen, U Bhargava, HK Moe, et al., Isolation of monoclonal antibodies recognizing rat bone-associated molecules in vitro and in vivo, J Histochem Cytochem, 40, 1339 (1992).
JJ van den Beucken, XF Walboomers, OC Boerman, et al., Functionalization of multilayered DNA-coatings with bone morphogenetic protein 2, J Control Release, 113, 63 (2006).
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this paper
Rights and permissions
About this article
Cite this article
Kim, S.E., Yun, YP., Park, K. et al. The effects of functionalized titanium with alendronate and bone morphogenic protein-2 for improving osteoblast activity. Tissue Eng Regen Med 10, 353–361 (2013). https://doi.org/10.1007/s13770-013-1098-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13770-013-1098-5